Literature DB >> 2998058

Effect of herpes simplex virus type 1 on cellular pools of oligosaccharide-lipid.

T Compton, R J Courtney.   

Abstract

Incorporation of [3H]mannose into cellular pools of mannosylphosphoryl dolichol (Man-P-Dol), oligosaccharide-lipid, and glycoprotein was measured and compared in herpes simplex virus type 1 (HSV-1)-infected cells and -uninfected cells. While mannose incorporation into the monosaccharide-dolichol fraction was similar in infected or uninfected Vero cells, incorporation into the oligosaccharide-lipid fraction was markedly reduced in HSV-1-infected cells (64% of control levels). In contrast, mannose incorporation into glycoprotein was significantly increased in virus-infected cells versus uninfected cells (194% of control levels). The kinetics of incorporation into the various fractions was examined and it was determined that there was minimal increase in mannose incorporation into oligosaccharide-lipid after 8 hr postinfection in virus-infected cells. This corresponded to the time at which nonglycosylated precursors of the HSV-1 glycoproteins were first detected in association with the nuclear fraction. These data suggest that there is an accelerated turnover of oligosaccharide-lipid in virus-infected Vero cells which is most likely due to extensive glycoprotein synthesis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998058     DOI: 10.1016/0042-6822(85)90221-1

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  2 in total

1.  Differential rates of processing and transport of herpes simplex virus type 1 glycoproteins gB and gC.

Authors:  M Sommer; R J Courtney
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

2.  Mannose-6-phosphate regulates destruction of lipid-linked oligosaccharides.

Authors:  Ningguo Gao; Jie Shang; Dang Huynh; Vijaya L Manthati; Carolina Arias; Heather P Harding; Randal J Kaufman; Ian Mohr; David Ron; John R Falck; Mark A Lehrman
Journal:  Mol Biol Cell       Date:  2011-07-07       Impact factor: 4.138

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.